2004
Characterizing ectopic pregnancies that rupture despite treatment with methotrexate
Dudley P, Heard M, Sangi-Haghpeykar H, Carson S, Buster J. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertility And Sterility 2004, 82: 1374-1378. PMID: 15533363, DOI: 10.1016/j.fertnstert.2004.03.066.Peer-Reviewed Original ResearchConceptsTubal ruptureEctopic pregnancyRisk factorsHCG valuesHuman chorionic gonadotropin valuesRetrospective case-control analysisIndependent risk factorUrban medical centerCase-control analysisConcentrations of hCGEctopic gestationMTX administrationIndependent predictorsSurgical interventionGonadotropin valuesHCG concentrationsMAIN OUTCOMEMedical CenterMethotrexateImplantation sitesPregnancyTubal isthmusPatientsPredictive variablesTreatment
1989
Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy
Carson S, Stovall T, Umstot E, Andersen R, Ling F, Buster J. Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy. Fertility And Sterility 1989, 51: 593-597. PMID: 2466704, DOI: 10.1016/s0015-0282(16)60605-2.Peer-Reviewed Original ResearchConceptsHuman chorionic somatomammotropinEctopic pregnancyBeta-human chorionic gonadotropinEctopic pregnancy ruptureChorionic somatomammotropinSurgical therapyBeta-hCGMethotrexate chemotherapyMethotrexate treatmentMedical managementTrophoblastic activityHCS levelsChorionic gonadotropinAuthors' seriesPregnancyPatientsSensitive indicatorRuptureChemotherapyGonadotropinMethotrexateProgesteroneTherapyWomen